TCT 2012: New trials and positive results for cardiac implants
Micro Interventional Devices initiates 1st-in-man EU study for its Permaseal
Cardiovascular medical device company Micro Interventional Devices launched a 1st-in-man European clinical study for its Permaseal cardiac closure, a device which combines soft tissue anchors and biocompatible elastomers that form a "web" around the myocardial access site, the company said.
The study will enroll 40 patients at 5 E.U. sites, and MID expects data to be available by Q1 2013.